van Deursen, A M MSchurink-Van't Klooster, T MMan, W Hvan de Kassteele, Jvan Gageldonk-Lafeber, A BBruijning-Verhagen, P C J Lde Melker, H ESanders, E A MKnol, M J2018-04-052018-04-052017Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands. 2017, 35 (51):7107-7113 Vaccine1873-25182914638110.1016/j.vaccine.2017.10.090http://hdl.handle.net/10029/621757The long-term impact of pneumococcal conjugate vaccines on pneumonia hospitalizations in all age-groups varies between countries. In the Netherlands, the 7-valent pneumococcal conjugate vaccine (PCV7) was implemented for newborns in 2006 and replaced by PCV10 in 2011. We assessed the impact of PCVs on community-acquired pneumonia (CAP) hospitalization rates in all age-groups.eninfo:eu-repo/semantics/closedAccessArticleVaccine 2017; 35(51):7107-13